Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 93–93 | Cite as

Brivanib-alaninate

Various toxiciites: case report
Case report
  • 10 Downloads

Reference

  1. Zhu H, et al. Treatment with Brivanib alaninate as a second-line monotherapy after Sorafenib failure in hepatocellular carcinoma: A case report. Medicine 98: e14823, No. 10, Mar 2019. Available from: URL: http://doi.org/10.1097/MD.0000000000014823 - ChinaCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations